Cartography will be eligible to receive more than $850 million, if Pfizer exercises all options and brings a drug from the collaboration to the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback